|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - CHF | -.--% |
|
-.--% | - |
| 07-07 | DOCMORRIS : Jefferies reiterates its Buy rating | ZD |
| 07-01 | Redcare Continues Its Comeback, Shares Have Easily More Than Doubled Since March | DP |
Company Valuation: DocMorris AG
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 2,412 | 320.6 | 860.2 | 257.7 | 289.2 | 424.6 | - | - |
| Change | - | -86.71% | 168.32% | -70.05% | 12.22% | 46.84% | - | - |
| Enterprise Value (EV) 1 | 2,714 | 723.2 | 1,137 | 486.1 | 426.8 | 625.8 | 663 | 676 |
| Change | - | -73.36% | 57.22% | -57.25% | -12.21% | 46.65% | 5.94% | 1.96% |
| P/E | -10.1x | -1.61x | 10.5x | -2.42x | -1.71x | -5.69x | -10.8x | -20.4x |
| PBR | 5.44x | 0.84x | 2.01x | 0.69x | 0.7x | 1.39x | 1.41x | 1.63x |
| PEG | - | 0.1x | -0x | 0x | 0x | 0.1x | 0.2x | 0.4x |
| Capitalization / Revenue | 1.4x | 0.2x | 0.89x | 0.25x | 0.26x | 0.35x | 0.31x | 0.29x |
| EV / Revenue | 1.57x | 0.45x | 1.18x | 0.48x | 0.38x | 0.51x | 0.48x | 0.46x |
| EV / EBITDA | -19x | -9.31x | -29.6x | -10x | -8.85x | -33.4x | 36.2x | 13.3x |
| EV / EBIT | -14x | -5.15x | -13.7x | -5.41x | -4.41x | -9.45x | -18.1x | -54.2x |
| EV / FCF | -14x | -3.87x | -9.88x | -8.81x | -3.68x | -8.88x | -20.9x | -47.1x |
| FCF Yield | -7.15% | -25.9% | -10.1% | -11.4% | -27.2% | -11.3% | -4.79% | -2.13% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -23.4 | -15.88 | 7.05 | -8.25 | -3.47 | -1.589 | -0.8337 | -0.444 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 1,726 | 1,608 | 966.9 | 1,017 | 1,124 | 1,220 | 1,371 | 1,466 |
| EBITDA 1 | -142.6 | -77.7 | -38.4 | -48.6 | -48.24 | -18.72 | 18.32 | 51 |
| EBIT 1 | -193.8 | -140.3 | -83.2 | -89.8 | -96.86 | -66.25 | -36.72 | -12.48 |
| Net income 1 | -225.7 | -171.1 | 82.2 | -97.3 | -134.4 | -83.51 | -46.79 | -27.42 |
| Net Debt 1 | 302.8 | 402.6 | 276.8 | 228.4 | 137.6 | 201.2 | 238.4 | 251.4 |
| Reference price 2 | 235.500 | 25.560 | 73.750 | 19.980 | 5.950 | 9.045 | 9.045 | 9.045 |
| Nbr of stocks (in thousands) | 10,240 | 12,543 | 11,664 | 12,897 | 48,599 | 48,889 | - | - |
| Announcement Date | 3/24/22 A | 3/24/23 A | 3/20/24 A | 3/12/25 A | 3/18/26 A | - | - | - |
1CHF in Million2CHF
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 16.62x | 0.75x | 7.76x | 2.24% | 6.11B | |
| 12.8x | 0.81x | 5.86x | 3.35% | 3.61B | |
| 15.52x | 0.94x | 7.03x | 4.16% | 3.2B | |
| 14.38x | 1.22x | 7.41x | 5.75% | 3.21B | |
| 13.66x | 0.56x | 4.46x | 5.06% | 2.98B | |
| 39.4x | - | - | - | 2.56B | |
| 22.95x | 0.66x | 8.44x | 1.79% | 1.67B | |
| -89.53x | 0.47x | 17.46x | 0.01% | 1.55B | |
| Average | 5.73x | 0.77x | 8.35x | 3.19% | 3.11B | |
| Weighted average by Cap. | 11.43x | 0.80x | 7.58x | 3.39% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ROSE Stock
- ROSE Stock
- Valuation DocMorris AG
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
